FIELD: biotechnology.
SUBSTANCE: invention relates to the field of biotechnology, in particular to a nucleic acid molecule encoding an antigen containing the LAP2-Emerin-MAN1, 1 (LEMD1) domain, as well as to the vector and composition containing it. An antigen containing the LAP2Emerin-MAN1, 1 (LEMD1) domain, as well as a vaccine containing it, has also been disclosed.
EFFECT: invention is effective for the treatment or prevention of cancer expressing an antigen containing the LEMD1 domain, as well as for vaccination of the subject against cancer cells expressing LEMD1.
22 cl, 15 dwg, 10 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTI-CANCER VACCINES TARGETING MUC16 AND THEIR USE | 2018 |
|
RU2750689C1 |
| MUC16-TARGETING ANTICANCER VACCINES AND APPLICATION THEREOF | 2018 |
|
RU2777918C2 |
| SURVIVIN-TARGETED ANTI-CANCER VACCINES AND APPLICATIONS THEREOF | 2018 |
|
RU2776949C2 |
| ANTI-CANCER VACCINES TARGETED WITH SURVIVIN AND THEIR APPLICATION | 2018 |
|
RU2751253C1 |
| ANTICANCER VACCINES TARGETING BORIS AND METHODS OF THEIR APPLICATION | 2018 |
|
RU2759681C1 |
| BORIS-TARGETED ANTI-CANCER VACCINES AND METHODS FOR APPLICATION THEREOF | 2018 |
|
RU2799786C2 |
| ANTI-CANCER VACCINES TARGETING PRAME AND THEIR APPLICATIONS | 2018 |
|
RU2748903C1 |
| MESOTHELINE-TARGETED CANCER VACCINES AND THEIR APPLICATION | 2018 |
|
RU2751252C1 |
| CHIMERIC OSPA GENES, PROTEINS AND THEIR APPLICATION METHODS | 2011 |
|
RU2773402C2 |
| IMMUNOGENS FOR VACCINATION AGAINST HIV | 2013 |
|
RU2721274C2 |
